These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diagnostic Superiority of 18 F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis : A Comparative Study With Insights Into Faciobrachial Dystonic Seizures Mechanisms and Recurrence Identification. Liang M, Niu N, Jia C, Fan S, Liu L, Cui R, Guan H. Clin Nucl Med; 2023 Nov 01; 48(11):e516-e522. PubMed ID: 37703438 [Abstract] [Full Text] [Related]
5. Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis. Sadaghiani MS, Roman S, Diaz-Arias LA, Habis R, Venkatesan A, Probasco JC, Solnes LB. Neuroradiology; 2023 Aug 01; 65(8):1225-1238. PubMed ID: 37264220 [Abstract] [Full Text] [Related]
7. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study. Muñoz-Lopetegi A, Guasp M, Prades L, Martínez-Hernández E, Rosa-Justícia M, Patricio V, Armangué T, Rami L, Borràs R, Castro-Fornieles J, Compte A, Gaig C, Santamaria J, Dalmau J, Spanish anti-LGI1 Encephalitis Study Group. Lancet Neurol; 2024 Mar 01; 23(3):256-266. PubMed ID: 38365378 [Abstract] [Full Text] [Related]
19. Anti-leucine-rich glioma inactivated protein 1 encephalitis with sleep disturbance as the first symptom: A case report and review of literature. Kong DL. World J Clin Cases; 2023 Jan 16; 11(2):408-416. PubMed ID: 36686352 [Abstract] [Full Text] [Related]